Vivasure Medical specializes in innovative medical devices designed for minimally invasive vessel closure, particularly in cardiology, interventional radiology, and vascular surgery. Their flagship product, the PerQseal device, is a fully absorbable synthetic implant that provides a sutureless solution for large-bore vessel punctures. This device is engineered to facilitate rapid and secure closure of arteriotomies up to 24F, eliminating the need for pre-procedural steps and allowing for straightforward deployment. The implant is designed to be fully absorbed within 180 days, promoting healing and restoring the vessel to its pre-procedure state without leaving any permanent materials behind.

The company is currently advancing its technology with the next-generation PerQseal+ device, which features an enhanced bioabsorbable patch aimed at addressing more complex patient anatomies. This new iteration is part of the Frontier V study, which evaluates its effectiveness in managing challenges associated with large-bore vascular procedures, such as transcatheter aortic valve replacement (TAVR) and endovascular aneurysm repair (EVAR). The PerQseal+ device aims to improve patient outcomes by providing a reliable and efficient closure method, thereby reducing the risks and complications associated with access-site management in interventional cardiology.

Ireland

The company develops advanced polymer implants and delivery systems, primarily focused on minimally invasive vessel closure in cardiology, interventional radiology and vascular surgery.

Vivasure Medical

Company Details